BioCryst: 2Q Earnings Snapshot
DURHAM, N.C. (AP) _ BioCryst Pharmaceuticals Inc. (BCRX) on Tuesday reported a loss of $37.6 million in its second quarter.
The Durham, North Carolina-based company said it had a loss of 34 cents per share.
The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.
The drugmaker posted revenue of $1.4 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $2.5 million.
The company’s shares closed at $2.84. A year ago, they were trading at $5.80.